Telix Pharmaceuticals Limited (TLX)
NASDAQ: TLX · Real-Time Price · USD
11.45
+0.60 (5.53%)
At close: Sep 2, 2026, 4:00 PM EDT
11.99
+0.54 (4.72%)
Pre-market: Sep 3, 2026, 6:15 AM EDT
Telix Pharmaceuticals Employees
As of December 31, 2025, Telix Pharmaceuticals had 1,184 total employees, including 1,120 full-time and 64 part-time employees. The number of employees increased by 950 or 405.98% compared to the previous year.
Employees
1,184
Change
950
Growth
405.98%
Revenue / Employee
$752,352
Profits / Employee
$28,291
Market Cap
3.82B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 1,184 | - | - | 1,120 | 64 |
| Mar 31, 2024 | 431 | 197 | 84.19% | 415 | 16 |
| Dec 31, 2022 | 234 | 76 | 48.10% | 234 | 0 |
| Dec 31, 2021 | 158 | - | - | 158 | 0 |
| Dec 31, 2017 | 9 | - | - | 9 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| Legend Biotech | 2,965 |
| Iovance Biotherapeutics | 975 |
| Arcus Biosciences | 601 |
| AbCellera Biologics | 562 |
| Denali Therapeutics | 507 |
| Relay Therapeutics | 202 |
| IDEAYA Biosciences | 145 |
| Tango Therapeutics | 137 |
TLX News
- 1 day ago - Telix Completes Patient Enrollment In BiPASS Trial, Aligns With FDA On NDA Filing; Stock Up - Nasdaq
- 1 day ago - 6 After-Hours Healthcare Gainers: Universe Pharma, BioAffinity, Modular Medical, Telix Pharma & More - Nasdaq
- 1 day ago - Telix Completes Enrollment in Phase 3 BiPASS Study, Aligns with FDA on NDA Pathway - GlobeNewsWire
- 2 days ago - Telix Appoints Gill As Board Chairman - Nasdaq
- 2 days ago - Telix Appoints David Gill as Chair - GlobeNewsWire
- 8 days ago - Telix Pharmaceuticals (ASX:TLX) -- Navigating Regulatory Challenges | WS Amati Global ... - GuruFocus
- 14 days ago - Telix Pharma H1 Revenue Jumps 22%; Reaffirms FY2026 Revenue Guidance; Stock Up - Nasdaq
- 14 days ago - Telix Pharmaceuticals H1 Earnings Call Highlights - MarketBeat